6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent

Details for Australian Patent Application No. 2004275728 (hide)

Owner Wyeth Holdings Corporation

Inventors Ayral-Kaloustian, Semiramis; Zhang, Nan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004275728

PCT Pub. Number WO2005/030218

Priority 60/505,486 24.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030218 Priority application(s): WO2005/030218

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275733-5-arylpyrimidines as anticancer agents

2004275727-Fluid delivery device identification and loading system